$NTHI SEC Filings

Filed On	Filing
22 Oct 2026	8-K: Regulation FD Disclosure NeOnc Technologies and the Department of Health – Abu Dhabi Sign MoU to Advance Brain Cancer Research and Proposed Clinical Collaboration
15 Oct 2026	Form 3: Alabedin Ali Mohammad Ahmad Mohammad, Director No securities owned
15 Oct 2026	8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Regulation FD Disclosure With UAE authorizations for both lead drug candidates, NeOnc brings a clinical development perspective to discussions on capital, precision medicine and international collaboration
28 Sep 2026	8-K: Regulation FD Disclosure November 17 meeting will address Phase 2 study design and potential regulatory pathways
21 Sep 2026	8-K: Material Modifications to Rights of Security Holders; Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year +1 more NeOnc Technologies Redeems All Outstanding Series A Convertible Preferred Stock and Eliminates Related Potential Dilution
18 Sep 2026	Form 4: Garnett Keithly, CFO Acquired 5,000 shares (Open Market Sale) ($16.8K)
17 Sep 2026	8-K: Regulation FD Disclosure CEO Amir Heshmatpour has purchased 111,000 shares for approximately $418,700 since the Company announced positive NEO100 Phase 2a results
15 Sep 2026	Form 4: Heshmatpour Amir F, Director Bought 15,000 shares ($59.4K) · Bought 35,000 shares ($115K)
15 Sep 2026	Form 4: Chen Thomas C, Director Bought 5,556 shares ($20K) · Bought 5,242 shares ($20K)
15 Sep 2026	Form 4: Garnett Keithly, CFO Bought 257 shares ($1K)
15 Sep 2026	144
14 Sep 2026	Form 4: Heshmatpour Amir F, Director Bought 37,000 shares ($136K)
10 Sep 2026	424B5
10 Sep 2026	8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure NeOnc Technologies Holdings, Inc. Announces Pricing of $15Million Registered Direct Offering Priced At-The-Market UnderNasdaq Rules with New and Existing Institutional Investors
21 Aug 2026	8-K/A: Departure/Election of Directors or Officers; Compensation Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
20 Aug 2026	Form 4: Chen Thomas C, Director Bought 12,757 shares ($70K)
20 Aug 2026	Form 4/A: Chen Thomas C, Director Bought 948 shares ($4.9K) · Bought 10,000 shares ($48K) · Bought 33,787 shares ($130K) · 1 more
20 Aug 2026	8-K: Submission of Matters to a Vote of Security Holders
18 Aug 2026	Form 4: Chen Thomas C, Director Bought 33,787 shares ($130K) · Bought 2,472 shares ($10K)
18 Aug 2026	Form 4: Heshmatpour Amir F, Director Bought 9,000 shares ($49.9K)

Comments